Siponimod
Category: Multiple SclerosisSiponimod Overview
Siponimod, sold under the brand name Mayzent, is a selective sphingosine-1-phosphate receptor modulator for oral use that is used for multiple sclerosis (MS).[7] It is intended for once-daily oral administration.[8][7] In March 2019, it was approved in the United States to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.&a...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Siponimod
Recent Siponimod Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Siponimod
- Tablet: 0.25mg, 2mg
Other drugs which contain Siponimod or a similar ingredient: (1 result)
- MAYZENT Siponimod